In a previous study on children with Down's syndrome a reduced rate of infections was reported by their parents after the children had received six months' treatment with selenium supplements. In the present study the concentrations of the four IgG subclasses were measured in 29 of these children in samples of serum obtained before and immediately after the period of supplementation and one year after it had finished. Selenium had a significant augmentative effect on the serum concentrations of IgG2 and IgG4, but not of IgG, and IgG3. This effect was not related to age, as among children over the age of 6 years the serum concentrations of IgG2 and IgG4 had decreased significantly one year after the treatment had been stopped. This study suggests that selenium has an immunoregulatory effect, which might be of importance in both basic research and clinical practice.
Susceptibility to infections is a feature of Down's syndrome and is likely to be caused by abnormalities in host defence-for example, in the immune response. ' In patients with Down's syndrome the serum concentration of IgG is either normal or slightly raised. ' The serum concentrations of the IgG2 and IgG4 subclasses are significantly reduced, and those of IgG, and IgG3 are normal or increased in both adults2 and children with Down's syndrome (G Anneren et al, unpublished observations). In a study of six months' selenium supplementation in children with Down's syndrome that was designed to investigate the effect on the activity of glutathione peroxidase in erythrocytes and on the concentrations of selenium in the plasma and erythrocytes, many of the parents spontaneously reported a reduced rate of infections among their children after treatment with selenium. 3 Older patients with Down's syndrome tend to develop a presenile dementia that has striking similarities to Alzheimer's disease. It has been suggested that this might be due to increased lipid peroxidation as a secondary gene dosage effect of the 50% increase in the activity of superoxide dismutase in trisomy 21 cells. The rationale for selenium supplementation was to fid out whether the activity of the selenium dependent enzyme glutathione peroxidase would increase and improve the protection against oxygen radicals. The results of the present study were unexpected and no explanation of the mechanisms of action can be offered. Further studies are under way to elucidate the immunoregulatory effect of selenium and to find out if it can be of any clinical value in the management of infection prone children, with or without Down's syndrome.
